Evidence map›Paper›PMID 28219612›Full record

Trial reportThe Lancet. Respiratory medicine2017

Hyperoxia and hypertonic saline in patients with septic shock (HYPERS2S): a two-by-two factorial, multicentre, randomised, clinical trial.

Pierre Asfar, Frédérique Schortgen, Julie Boisramé-Helms, Julien Charpentier, Emmanuel Guérot, Bruno Megarbane, David Grimaldi, Fabien Grelon, Nadia Anguel, Sigismond Lasocki and 19 more

Erratum issued Registry-linked trialAbstract readMulticenter StudyRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in The Lancet. Respiratory medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT05029167 (REstrictive Versus LIberal Oxygen Strategy and Its Effect on Pulmonary Hypertension After Out-of-hospital Cardiac Arrest), which is not on this map. Cited by 128 papers, 16 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
128citing papers in PubMed, 16 pooled it
17.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05029167 naunknown statusnot on this map

REstrictive Versus LIberal Oxygen Strategy and Its Effect on Pulmonary Hypertension After Out-of-hospital Cardiac Arrest (RELIEPH-study): a Substudy Protocol for a Randomised Clinical Trial

TypeinterventionalSponsorUniversity of Southern DenmarkRan2017 to 2023Enrolled300ConditionsHypertension, Pulmonary Arterial, Out-Of-Hospital Cardiac Arrest, Intensive Care Unit, Oxygen TherapyArmsRestrictive PaO2, Low normal MAP, Liberal PaO2, High normal MAP
3 · Its place in the literature

Who cites it

128 citing papers in PubMed, 16 syntheses or guidelines pooled it, 301 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Conservative versus liberal oxygen therapy in mechanically ventilated patients: A systematic review with meta-analysis.Canadian journal of respiratory therapy : CJRT = Revue canadienne de la therapie respiratoire : RCTR · 2025
    Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. [Oxygen in the acute care of adults : Short version of the German S3 guideline].Medizinische Klinik, Intensivmedizin und Notfallmedizin · 2022
    Guideline
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Pooled it
  15. Pooled it
  16. Pooled it
  17. Trial
  18. Trial
  19. Trial
  20. Trial

68 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

29 authors at 19 institutions in 1 country.

Pierre AsfarDépartement de Réanimation Médicale et de Médecine Hyperbare, Angers, France. Electronic address: piasfar@chu-angers.fr.
Frédérique SchortgenService de Réanimation Médicale, Centre Hospitalo-Universitaire Henri Mondor, APHP, Créteil, France.
Julie Boisramé-HelmsService de Réanimation Médicale, Nouvel Hôpital Civil, Centre Hospitalo-Universitaire, Strasbourg, France.
Julien CharpentierService de Réanimation Médicale, Centre Hospitalo-Universitaire Cochin, APHP, Paris, France.
Emmanuel GuérotService de Réanimation Médicale, Hôpital Européen Georges Pompidou, APHP, Paris, France.
Bruno MegarbaneService de Réanimation Médicale, Centre Hospitalo-Universitaire Lariboisière, APHP, France.
David GrimaldiService de Réanimation, Centre Hospitalier Angré Mignot, Le Chesnay, France.
Fabien GrelonService de Réanimation, Centre hospitalier, Le Mans, France.
Nadia AnguelService de Réanimation Médicale, Centre Hospitalo-Universitaire Le Kremlin Bicêtre, APHP, France.
Sigismond LasockiDépartement d'Anesthésie Réanimation, Centre Hospitalo-Universitaire, Angers, France.
Matthieu Henry-LagarrigueService de Réanimation, Centre Hospitalier, La Roche sur Yon, France.
Frédéric GonzalezService de Réanimation Médicale, Centre Hospitalo-Universitaire Avicenne, APHP, France.
François LegayService de Réanimation, Centre Hospitalier, Saint Brieuc, France.
Christophe GuittonService de Réanimation Médicale, Centre Hospitalo-Universitaire Nantes, France.
Maleka SchenckService de Réanimation Médicale, Hôpital de Hautepierre, Centre Hospitalo-Universitaire, Strasbourg, France.
Jean Marc DoiseService de Réanimation, Centre Hospitalier, Chalon sur Saône, France.
Jérôme DevaquetService de Réanimation, Hôpital Foch, Suresnes, France.
Thierry Van Der LindenService de Réanimation, Centre Hospitalier Saint Philibert, Lomme, France.
Delphine ChatellierService de Réanimation Médicale, Centre Hospitalo-Universitaire, Poitiers, Paris, France.
Jean Philippe RigaudService de Réanimation, Centre Hospitalier, Dieppe, France.
Jean DellamonicaService de Réanimation, Centre Hospitalier-Universitaire, Nice, France.
Fabienne TamionService de Réanimation Médicale, Centre Hospitalier-Universitaire, Rouen, France.
Ferhat MezianiService de Réanimation Médicale, Nouvel Hôpital Civil, Centre Hospitalo-Universitaire, Strasbourg, France.
Alain MercatDépartement de Réanimation Médicale et de Médecine Hyperbare, Angers, France.
Didier DreyfussService de Réanimation Médicale, Centre Hospitalo-Universitaire Louis Mourier, APHP, Paris, France.
Valérie SeegersDepartment of Statistics, Institut de Cancérologie de l'Ouest, Angers, France.
Peter RadermacherInstitut für anesthesiologische Pathophysiologie und Verfahrensentwicklung, Universitätklinikum Ulm, Ulm, Germany.
HYPER2S Investigators
REVA research network
Hôpital Civil, Strasbourg · FRAssistance Publique – Hôpitaux de Paris · FRBicêtre Hospital · FRCentre Hospitalier Départemental Vendée · FRCentre Hospitalier de Saint-Brieuc · FRCentre Hospitalier du Mans · FRCentre Hospitalier Universitaire d'Angers · FRCentre Hospitalier Universitaire de Nantes · FRCentre Hospitalier Universitaire de Nice · FRCentre Hospitalier Universitaire de Poitiers · FRCentre Hospitalier Universitaire de Rouen · FRHôpital André Mignot · FRHôpital Avicenne · FRHôpital d'Hautepierre · FRHôpital Européen · FRHôpital Foch · FRHôpital Louis-Mourier · FRHôpital Saint-Philibert · FRInstitut de Cancérologie de l'Ouest · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere is insufficient research into the use of mechanical ventilation with increased inspiratory oxygen concentration (FiO

methodsThis two-by-two factorial, multicentre, randomised, clinical trial (HYPERS2S) recruited patients aged 18 years and older with septic shock who were on mechanical ventilation from 22 centres in France. Patients were randomly assigned 1:1:1:1 to four groups by a computer generated randomisation list stratified by site and presence or absence of acute respiratory distress syndrome by use of permuted blocks of random sizes. Patients received, in an open-labelled manner, mechanical ventilation either with FiO

findingsBetween Nov 3, 2012, and June 13, 2014, 442 patients were recruited and assigned to a treatment group (normoxia [n=223] or hyperoxia [n=219]; isotonic [n=224] or hypertonic [n=218]). The trial was stopped prematurely for safety reasons. 28 day mortality was recorded for 434 patients; 93 (43%) of 217 patients had died in the hyperoxia group versus 77 (35%) of 217 patients in the normoxia group (hazard ratio [HR] 1·27, 95% CI 0·94-1·72; p=0·12). 89 (42%) of 214 patients had died in the hypertonic group versus 81 (37%) of 220 patients in the isotonic group (HR 1·19, 0·88-1·61; p=0·25). We found a significant difference in the overall incidence of serious adverse events between the hyperoxia (185 [85%]) and normoxia groups (165 [76%]; p=0·02), with a clinically relevant doubling in the hyperoxia group of the number of patients with intensive care unit-acquired weakness (24 [11%] vs 13 [6%]; p=0·06) and atelectasis (26 [12%] vs 13 [6%]; p=0·04) compared with the normoxia group. We found no statistical difference for serious adverse events between the two saline groups (p=0·23).

interpretationIn patients with septic shock, setting FiO

fundingThe French Ministry of Health.

Indexed as

Respiration, ArtificialAgedFemaleFluid TherapyFranceHumansHyperoxiaIntensive Care UnitsIntention to Treat AnalysisMaleMiddle AgedResuscitationSaline Solution, HypertonicShock, SepticTreatment OutcomeSaline Solution, Hypertonic

Identifiers

PMID28219612
OpenAlexW2587881246

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.